Risk Appraisal on an International Scale
Background. A major concern for drug regulators, academic epidemiologists, and members of the pharmaceutical industry seems to be the development of a generally accepted approach to the assessment of drug-associated risks in the postmarketing phase in order to achieve safety standards that are both objective and rigorous.
Unable to display preview. Download preview PDF.